Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.65 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.65 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.65 |
| ▸ | CHRM4 known ✓ | P08173 | 1/20 | 0.65 |
| ▸ | CHRM5 known ✓ | P08912 | 1/20 | 0.65 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.65 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.95 |
| ▸ | MEN1 | O00255 | 4/20 | 0.95 |
| ▸ | MAPT | P10636 | 3/20 | 0.95 |
| ▸ | TP53 | P04637 | 1/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.95 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.95 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.95 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.95 |
| ▸ | HTT | P42858 | 5/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.91 |
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.91 |
| ▸ | NPC1 | O15118 | 1/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL30020476 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL4076484 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL30020567 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL598489 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL4077981 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL1946113 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| Bromide SCHEMBL8364659 | 1.00 | KMT2A (0.95) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3196438 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3215753 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 | |
| SCHEMBL3221223 | 0.98 | KMT2A (1.00) | KMT2AMEN1MAPTTP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257478-A1 | APPARATUS AND METHOD FOR PRODUCTION OF FORMATE FROM CARBON DIOXIDE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2025-08-14 | — | — | US | claimed |
| CN-119575678-A | Full-automatic anti-dazzle AR glasses based on electrochromic technology | 哈尔滨工业大学 | 2025-03-07 | — | — | CN | claimed |
| US-12216099-B2 | Detection method based on supercritical fluid chromatography and post-column ionic liquid charge complexation | CHINESE ACADEMY OF INSPECTION AND QUARANTINE (CN) | 2025-02-04 | — | — | US | claimed |
| US-20220229027-A1 | DETECTION METHOD BASED ON SUPERCRITICAL FLUID CHROMATOGRAPHY AND POST-COLUMN IONIC LIQUID CHARGE COMPLEXATION | CHINESE ACADEMY OF INSPECTION AND QUARANTINE (CN) | 2022-07-21 | — | — | US | claimed |
| US-20050148734-A1 | Aqueous room temperature living radical polymerization of vinyl halides | UNIVERSITY OF PENNSYLVANIA | 2005-07-07 | — | — | US | claimed |
| US-6911515-B2 | Aqueous room temperature living radical polymerization of vinyl halides | UNIVERSITY OF PENNSYLVANIA (US) | 2005-06-28 | — | — | US | claimed |
| US-20030078353-A1 | Aqueous room temperature living radical polymerization of vinyl halides | UNIVERSITY OF PENNSYLVANIA | 2003-04-24 | — | — | US | claimed |
| US-12447437-B2 | Carbon dioxide adsorption-desorption device | KABUSHIKI KAISHA TOSHIBA (JP) | 2025-10-21 | — | — | US | disclosed |
| US-20250304528-A1 | OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-10-02 | — | — | US | disclosed |
| US-12398134-B2 | N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250257478-A1 | APPARATUS AND METHOD FOR PRODUCTION OF FORMATE FROM CARBON DIOXIDE | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2025-08-14 | — | — | US | disclosed |
| WO-2025111251-A1 | COMPOUNDS THAT INHIBIT POLO-LIKE KINASE 4 | EXELIXIS, INC. (US) | 2025-05-30 | — | — | WO | disclosed |
| US-12275685-B2 | Oligo-benzamide analogs and their use in cancer treatment | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-15 | — | — | US | disclosed |
| WO-2003002621-A1 | RADICAL POLYMERIZATION OF VINYL HALIDE | UNIVERSITY OF PENNSYLVANIA (US) | 2003-01-09 | — | — | WO | disclosed |
| US-6284796-B1 | NAPHTHAMIDINE COMPOUNDS | ABBOTT LABORATORIES | 2001-09-04 | — | — | US | disclosed |
| US-6121386-A | A SURFACE COATING TO IMPROVE OLEFIN RESIN FILMS COATABILITY E.G., ADHESION, COMPRISING A BLEND OF EPOXIDIZED BLOCK COPOLYMER OF AN AROMATIC VINYL COMPOUND AND A CONJUGATED DIENE, AND A POLYMER WITH A REACTIVE FUNCTIONAL GROUP | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-09-19 | — | — | US | disclosed |
| US-5886136-A | Pattern forming process | NIPPON ZEON CO., LTD. (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0879861-A1 | RESIN COMPOSITIONS FOR COATING | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-25 | — | — | EP | disclosed |
| US-5777068-A | Photosensitive polyimide resin composition | NIPPON ZEON CO., LTD. (JP) | 1998-07-07 | — | — | US | disclosed |
| EP-0702270-A2 | Photosensitive polyimide resin composition | NIPPON ZEON CO., LTD. (JP) | 1996-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304528-A1 | OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT | OGFR, OTC, HDAC6 | CHRM2 4419/4885CHRM1 4756/4885ACHE 2118/4885 |
| US-12398134-B2 | N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods | IFNG, IFNAR1, CCL5 | CHRM2 552/4885CHRM1 193/4885ACHE 3001/4885 |
| US-12275685-B2 | Oligo-benzamide analogs and their use in cancer treatment | OGFR, OTC, HDAC6 | CHRM2 4419/4885CHRM1 4756/4885ACHE 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.